Alexion
Manufacturing · Massachusetts, United States · 5,000 Employees
View Company Info for Free
About
Headquarters
121 Seaport Blvd, Boston, Massachusetts, 02210,...Phone Number
(475) 230-2596Website
www.alexion.comRevenue
$1.4 BillionIndustry
Most Recent Scoops
Highlights
$18M
Total Funding Amount
$18M
Most Recent Funding Amount
1
Number of Funding Rounds
Who is Alexion
Alexion Org Chart
Is Alexion your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Check if Alexion has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Alexion launches new products
Congratulate Masked Content for being promoted to Masked Content at Alexion
Website visits: Recent activity has been detected on your website
Check out if Alexion is spiking on competitors!
Funding: Get notified immidiatlly once Alexion has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Alexion had a recent Job posting/layoffs
Earning: See what the market has to say on Alexion recently announced quarterly report
Alexion, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Alexion
Find more new buyers
Compare Similar Companies to Alexion
Compare insights from companies similar to Alexion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Alexion
Alexion financials insights
Gather financial insights about Alexion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Alexion Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Alexion Tech Stack
A closer look at the technologies used by Alexion
Most Recent Scoops
Alexion News & Media
AstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading and diverse pipeline in hematology at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition December 7-10, 2024. A total of 57 abstracts will feature 13 approved and potential new medicines from across AstraZeneca’s portfolio and pipeline in hematology, including from Alexion, its rare disease group, with data in key settings including chroTwo former Alexion leaders fight through layoffs and a tough market to maintain a rare ...
Rallybio is headed into a mid-stage trial with enough cash through 2026, but the cyclical market has made the journey difficult.Voydeya approved in US
2 April 2024 Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with the rare disease PNH Approval of first-in-class, oral, Factor D inhibitor based on results from pivotal ALPHA Phase III trial Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular haemolysis (EVH) in adults with paroxysmal nocturnal haemoglobinuria (PNH).[1] Voydeya is a first-inVOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
WILMINGTON, Del.--(BUSINESS WIRE)--VOYDEYA™ (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular hemolysis (EVH) in adults with paroxysmal nocturnal hemoglobinuria (PNH).1 VOYDEYA is a first-in-class, oral, Factor D inhibitor developed as an add-on to standard-of-care ULTOMIRIS® (ravulizumab-cwvz) or SOLIRIS® (eculizumab) to address the needs of the approximately 10-20% of patients with PNH who experience clinically significan
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Alexion
Alexion is a global biopharmaceutical company focused on the discovery, development, and commercialization of medicines for severe and life-threatening rare disorders. The company was established in 1992 and is headquartered in Boston, Massachusetts.... Read More